Pain Management News

• 'Real-time Experiment': Compounded GLP-1s on Coupon Site Purveyors on coupon sites like Groupon are marketing weight loss programs that include compounded semaglutide and tirzepatide.
  Medscape Medical News, December 26, 2023
• Opioid Agonist Therapy Underused, Data Suggest The low rates of opioid agonist therapy administration over time suggest that additional efforts are needed to promote this intervention in acute care settings, according to the researchers.
  Medscape Medical News, December 22, 2023
• Monoclonal Antibodies: A New Treatment for Long COVID? A small study generated impressive results.
  Medscape Medical News, December 22, 2023
• Improving the Treatment of Sexual Dysfunction in Women Although sexual dysfunction is common and affects quality of life, female patients rarely broach the topic spontaneously.
  Medscape Medical News, December 22, 2023
• Childhood Adversity Linked to Adult Chronic Pain Adverse experiences early in life, especially including physical and sexual abuse, increase risk for chronic pain in adulthood.
  Medscape Medical News, December 22, 2023
• Your Patient Has a Drug Addiction, What's After Screening? Primary care clinicians can play a pivotal role in helping patients with substance abuse disorders achieve long-term recovery from addiction, through frequent checkup visits.
  Medscape Medical News, December 22, 2023
• Ukrainian Lawmakers Back Legalisation Of Medical Cannabis Ukrainian lawmakers voted to legalise the medical use of cannabis on Thursday after activists and supporters called for the step in order to treat millions of people...
  Reuters Health Information, December 21, 2023
• New Research Aims to Unravel Both ME/CFS and Long COVID A 2-day research conference sponsored by the US National Institutes of Health highlighted research that points to mechanisms that suggest potentially "druggable" pathways.
  Medscape Medical News, December 21, 2023
• Low-Dose Naltrexone Researcher Disputes Study Negativity Neuroinflammation expert Jarred Younger, PhD, disputes commentary calling for clinicians to stop prescribing the off-label compounded medication to reduce pain in people with fibromyalgia.
  Medscape Medical News, December 21, 2023
• A New Test Could Save Arthritis Patients Time, Money, Pain Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
  KFF Health News, December 21, 2023
• Despite X-Waiver Elimination, Buprenorphine Rx Decline After the elimination of the mandatory training required to prescribe buprenorphine for opioid use disorder, prescriptions for the drug declined the next year, new research shows.
  Medscape Medical News, December 20, 2023
• Female Patients With PCI Benefit From Abbreviated DAPT Women undergoing percutaneous coronary intervention who receive abbreviated rather than standard dual antiplatelet therapy have similar outcomes to men despite higher baseline risk.
  Medscape Medical News, December 20, 2023
• ESD Curbs Adenoma Recurrence but More Adverse Events For large colonic adenomas, endoscopic submucosal dissection reduces the recurrence rate compared with endoscopic mucosal resection, but the adverse event rate is higher.
  Medscape Medical News, December 20, 2023
• FDA Approves First Test to Identify Opioid Use Addiction Risk The U.S. Food and Drug Administration (FDA) said on Tuesday it has approved the first test to assess if there is a risk of opioid use addiction in certain...
  Reuters Health Information, December 19, 2023
• Migraine Experts: Head-to-Head Drug Comparisons Better Placebo-controlled trials are insufficient for decisions that affect medication availability in EU member states.
  Medscape Medical News, December 19, 2023
• Restarting CGRPs for Migraine May Lower Response Rate Restarting a CGRP monoclonal antibody (mAb) after a gap in treatment may lower response rate, a new study suggests. However, switching to a different mAb may counter this effect.
  Medscape Medical News, December 18, 2023
• Sickle Cell CRISPR Therapy May Offer 'Functional Cure' Patients with severe sickle cell disease could soon be freed from vaso-occlusive crises after receiving an infusion of exa-cel, the first gene-editing therapy to use CRISPR technology.
  Medscape Medical News, December 18, 2023
• Multiple Benefits of Mindfulness for Migraine, RCT Shows A mindfulness-based treatment has shown multiple benefits in patients with chronic migraine and medication-overuse headaches, results of a new randomized trial show.
  Medscape Medical News, December 18, 2023
• One Fifth of Americans Report Use of Hemp-Derived Products Adults who used delta-8 THC were more likely to live in states where cannabis use is illegal.
  Medscape Medical News, December 18, 2023
• Concerns Over Nalmefene Nasal Spray for Opioid Overdose Experts urge rigorous research due to safety concerns and uncertainties and prefer naloxone as the preferred first-line agent.
  Medscape Medical News, December 18, 2023
• 'Hidden Hearing Loss' May Cause Tinnitus: Study Some people who have tinnitus are still able to perform well on standard hearing tests, according to researchers at the Massachusetts Eye and Ear Infirmary.
  WebMD Health News, December 04, 2023
• ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
  MDedge News, December 04, 2023
• How Will the Supreme Court Reshape US Opioid Epidemic Relief? The Supreme Court is set on Monday to hear arguments over the legality of a roughly $6 billion bankruptcy settlement involving Purdue Pharma.
  Reuters Health Information, December 03, 2023
• Social Contagion Influences Buprenorphine Initiation for OUD Despite being safe and effective, emergency department initiation of buprenorphine for opioid use disorder remains an underutilized practice, necessitating the evaluation of factors affecting its adoption.
  Medscape Medical News, December 04, 2023
• Procedures May Ease Postmenopausal Pain Better Than Drugs Postmenopausal women report more significant improvements in chronic pain after procedural interventions when compared with their younger counterparts, despite being notably less likely to use muscle relaxants, TCAs, and benzodiazepines.
  Medscape Medical News, December 01, 2023
• Eight Wealth Tips Just for Doctors These money experts are doctors themselves and understand the unique financial needs of physicians. Here's what they suggest.
  Medscape Medical News, December 01, 2023
• What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
  Medscape Medical News, December 01, 2023
• FTC Chief Gears Up for a Showdown With Private Equity Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
  KFF Health News, December 01, 2023
• Drugs to Prevent vs Those to Treat Migraine Might Not Share Targets 'I think this explains some of the frustration at trigger modulation. I think we are often trying to modulate a process that has already got started,' said Dr Peter Goadsby of King's College London.
  MDedge News, November 29, 2023
• AANEM 2023 Novel Myasthenia Gravis Therapies Bring Opportunities New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.
  MDedge News, November 27, 2023
• Alert FDA Approves Nirogacestat for Desmoid Tumors This is the first drug approved to treat desmoid tumors.
  Medscape Medical News, November 27, 2023
• Metoclopramide Nasal Spray Eases Gastroparesis in Women A nasal spray formulation of metoclopramide was well tolerated and reduced symptoms of diabetic gastroparesis in women with moderate to severe baseline symptoms in a phase 3 study
  Medscape Medical News, November 27, 2023
• Chest Pain With Long COVID Common but Undertreated A Mayo Clinic study found nearly 90% of patients with long COVID experience chest pain, but treatment for this condition is not yet standardized.
  Medscape Medical News, November 22, 2023
• New Guidance on the Management of Stimulant Use Disorder Stimulant use disorder is common and deadly, but there’s been scant guidance to inform clinical management. Two professional societies have just released a comprehensive guideline.
  Medscape Medical News, November 22, 2023
• Chronic Pain in the US: New Data In 2020, 25% of US adults with chronic pain managed their symptoms with medication alone versus nonpharmalogic treatments such as physical, occupational, or cognitive behavioral therapies.
  Medscape Medical News, November 22, 2023
• WCN 2023 A Role for Neurologists in Diabetic Peripheral Neuropathy The rise in diabetic neuropathy over the last few decades has paralleled the obesity and related diabetes pandemics, one expert says, and neurologists have a role to play in controlling it.
  Medscape Medical News, November 21, 2023
• FDA Warns Against Using Cardinal's Syringes The FDA on Monday warned healthcare providers and facilities not to use Cardinal Health's Monoject syringes with patient-controlled pain management pumps and syringe pumps.
  Reuters Health Information, November 20, 2023
• Choosing the Right Approach to Cancer and Menopause Symptoms Hormone replacement therapy may be considered to lessen these symptoms, but only in certain conditions, said a gynecologist.
  Medscape Medical News, November 21, 2023
• ACR 2023 IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.
  MDedge News, November 20, 2023
• Rite Aid Sues US Justice Dept to Stop Opioid Lawsuit Rite Aid sued the US Department of Justice, seeking to block a lawsuit alleging that they ignored red flags and illegally filled hundreds of thousands of prescriptions for addictive opioid medication.
  Reuters Health Information, November 16, 2023